Inventor
SWEENEY ZACHARY KEVIN
US39 patents
⚠️ This page may combine multiple inventors who share the name “SWEENEY ZACHARY KEVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE PALO ALTO LLC
14 patentsUS7906509B2Mar 15, 2011
Inhibitors of bruton's tyrosine kinase
ROCHE PALO ALTO LLC26 citations92
US7208509B2Apr 24, 2007
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC26 citations92
US7189718B2Mar 13, 2007
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC33 citations92
US7683064B2Mar 23, 2010
Inhibitors of Bruton's tyrosine kinase
ROCHE PALO ALTO LLC22 citations90
US7166738B2Jan 23, 2007
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC32 citations90
US7348345B2Mar 25, 2008
Nonnucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC8 citations74
US7625949B2Dec 1, 2009
Methods for treating retroviral infections
ROCHE PALO ALTO LLC7 citations71
US7666891B2Feb 23, 2010
Heterocyclic antiviral compounds
ROCHE PALO ALTO LLC6 citations62
US7754919B2Jul 13, 2010
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC2 citations61
US7625897B2Dec 1, 2009
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC2 citations57
US7906540B2Mar 15, 2011
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC0 citations52
US7713974B2May 11, 2010
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC0 citations51
US8026362B2Sep 27, 2011
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC0 citations41
US7947709B2May 24, 2011
Non-nucleoside reverse transcriptase inhibitors
ROCHE PALO ALTO LLC0 citations41
GENENTECH INC
7 patentsUS8796296B2Aug 5, 2014
Aminopyrimidine derivatives as LRRK2 modulators
GENENTECH INC14 citations84
US8791130B2Jul 29, 2014
Aminopyrimidine derivatives as LRRK2 modulators
GENENTECH INC18 citations84
US9212173B2Dec 15, 2015
Pyrazole aminopyrimidine derivatives as LRRK2 modulators
GENENTECH INC18 citations83
US9145402B2Sep 29, 2015
Aminopyrimidine derivatives as LRRK2 modulators
GENENTECH INC15 citations83
US8809331B2Aug 19, 2014
Aminopyrimidine derivatives as LRRK2 modulators
GENENTECH INC12 citations83
US8802674B2Aug 12, 2014
Aminopyrimidine derivatives as LRRK2 modulators
GENENTECH INC12 citations82
US9139566B2Sep 22, 2015
Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (PET) imaging for LRRK2
GENENTECH INC6 citations72
NOVARTIS AG
6 patentsUS9814739B2Nov 14, 2017
2′-ethynyl nucleoside derivatives for treatment of viral infections
NOVARTIS AG2 citations71
US9815804B2Nov 14, 2017
Isoxazole hydroxamic acid compounds as LpxC inhibitors
NOVARTIS AG1 citations61
US10029994B2Jul 24, 2018
Isoxazole hydroxamic acid compounds as LpxC inhibitors
NOVARTIS AG0 citations51
US9718792B2Aug 1, 2017
Isoxazoline hydroxamic acid derivatives as LpxC inhibitors
NOVARTIS AG1 citations51
US10071973B2Sep 11, 2018
Crystalline isoxazole hydroxamic acid compounds
NOVARTIS AG0 citations50
US9566312B2Feb 14, 2017
Cyclic peptides and use as medicines
NOVARTIS AG0 citations50